Kynurenine 3-Monooxygenase Gene Associated With Nicotine Initiation and Addiction: Analysis of Novel Regulatory Features at 5′ and 3′-Regions
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Kynurenine 3-Monooxygenase Gene Associated With Nicotine Initiation and Addiction: Analysis of Novel Regulatory Features at 5′ and 3′-Regions
Authors
Keywords
-
Journal
Frontiers in Genetics
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-06-13
DOI
10.3389/fgene.2018.00198
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Biochemistry and structural studies of kynurenine 3-monooxygenase reveal allosteric inhibition by Ro 61-8048
- (2018) Jingjing Gao et al. FASEB JOURNAL
- Pathways to precision medicine in smoking cessation treatments
- (2018) Li-Shiun Chen et al. NEUROSCIENCE LETTERS
- Implications of CpG islands on chromosomal architectures and modes of global gene regulation
- (2018) Samuel Beck et al. NUCLEIC ACIDS RESEARCH
- Kynurenic Acid: The Janus-Faced Role of an Immunomodulatory Tryptophan Metabolite and Its Link to Pathological Conditions
- (2018) Elisa Wirthgen et al. Frontiers in Immunology
- Attenuating Nicotine Reinforcement and Relapse by Enhancing Endogenous Brain Levels of Kynurenic Acid in Rats and Squirrel Monkeys
- (2017) Maria E Secci et al. NEUROPSYCHOPHARMACOLOGY
- JASPAR 2018: update of the open-access database of transcription factor binding profiles and its web framework
- (2017) Aziz Khan et al. NUCLEIC ACIDS RESEARCH
- Gene suppression approaches to neurodegeneration
- (2017) Rhia Ghosh et al. Alzheimers Research & Therapy
- Predicting transcription factor site occupancy using DNA sequence intrinsic and cell-type specific chromatin features
- (2016) Sunil Kumar et al. BMC BIOINFORMATICS
- Kynurenine-3-monooxygenase: a review of structure, mechanism, and inhibitors
- (2016) Jason R. Smith et al. DRUG DISCOVERY TODAY
- Targeting of the kynurenic acid across the blood–brain barrier by core-shell nanoparticles
- (2016) N. Varga et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Free energy analysis and mechanism of base pair stacking in nicked DNA
- (2016) Florian Häse et al. NUCLEIC ACIDS RESEARCH
- SNPs in NRXN1 and CHRNA5 are associated to smoking and regulation of GABAergic and glutamatergic pathways
- (2016) Gloria Pérez-Rubio et al. PHARMACOGENOMICS
- Bioinformatic Analysis of Human OPN3 Alternative Promoters Associated with Cancer
- (2016) Mohammed A. Ibrahim Al-Obaide et al. Applied Mathematics & Information Sciences
- Identifying and functionally characterizing tissue-specific and ubiquitously expressed human lncRNAs
- (2016) Chunjie Jiang et al. Oncotarget
- Bioinformatic Analysis of Human OPN3 Alternative Promoters Associated with Cancer
- (2016) Mohammed A. Ibrahim Al-Obaide et al. Applied Mathematics & Information Sciences
- N-Methyl D-Aspartate Receptor Antagonist Kynurenic Acid Affects Human Cortical Development
- (2016) Inseyah Bagasrawala et al. Frontiers in Neuroscience
- Multifaceted roles of 5′-regulatory region of the cancer associated gene B4GALT1 and its comparison with the gene family
- (2015) MOHAMMED A. IBRAHIM AL-OBAIDE et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- CHRNA5 Risk Variant Predicts Delayed Smoking Cessation and Earlier Lung Cancer Diagnosis—A Meta-Analysis
- (2015) Li-Shiun Chen et al. JNCI-Journal of the National Cancer Institute
- Determining the role of microRNAs in psychiatric disorders
- (2015) Orna Issler et al. NATURE REVIEWS NEUROSCIENCE
- DTIE, a novel core promoter element that directs start site selection in TATA-less genes
- (2015) Nadav Marbach-Bar et al. NUCLEIC ACIDS RESEARCH
- BioGPS: building your own mash-up of gene annotations and expression profiles
- (2015) Chunlei Wu et al. NUCLEIC ACIDS RESEARCH
- Nicotine receptors mediating sensorimotor gating and its enhancement by systemic nicotine
- (2015) Farena Pinnock et al. Frontiers in Behavioral Neuroscience
- CHRNA5 Risk Variant Predicts Delayed Smoking Cessation and Earlier Lung Cancer Diagnosis—A Meta-Analysis
- (2015) Li-Shiun Chen et al. JNCI-Journal of the National Cancer Institute
- Kynurenine 3-Monooxygenase: An Influential Mediator of Neuropathology
- (2015) Jennifer M. Parrott et al. Frontiers in Psychiatry
- Bidirectional promoters are the major source of gene activation-associated non-coding RNAs in mammals
- (2014) Masahiro Uesaka et al. BMC GENOMICS
- Association of CHRNA5-A3-B4 SNP rs2036527 With Smoking Cessation Therapy Response in African-American Smokers
- (2014) A Z X Zhu et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Identification and consequences of miRNA–target interactions — beyond repression of gene expression
- (2014) Jean Hausser et al. NATURE REVIEWS GENETICS
- CHRNA5 Variant Predicts Smoking Cessation in Patients With Acute Myocardial Infarction
- (2014) Li-Shiun Chen et al. NICOTINE & TOBACCO RESEARCH
- Bidirectional promoters in the transcription of mammalian genomes
- (2013) A. S. Orekhova et al. BIOCHEMISTRY-MOSCOW
- Genomics and personalized medicine: CHRNA5-CHRNA3-CHRNB4 and smoking cessation treatment
- (2013) Li-Shiun Chen et al. JOURNAL OF FOOD AND DRUG ANALYSIS
- Structural basis of kynurenine 3-monooxygenase inhibition
- (2013) Marta Amaral et al. NATURE
- Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid
- (2013) Zuzana Justinova et al. NATURE NEUROSCIENCE
- miRBase: annotating high confidence microRNAs using deep sequencing data
- (2013) Ana Kozomara et al. NUCLEIC ACIDS RESEARCH
- Measurements of the Impact of 3′ End Sequences on Gene Expression Reveal Wide Range and Sequence Dependent Effects
- (2013) Ophir Shalem et al. PLoS Computational Biology
- Kynurenic acid as an antagonist of α7 nicotinic acetylcholine receptors in the brain: Facts and challenges
- (2012) Edson X. Albuquerque et al. BIOCHEMICAL PHARMACOLOGY
- The kynurenine pathway in neurodegenerative diseases: Mechanistic and therapeutic considerations
- (2012) Lin Tan et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Analysis of Detailed Phenotype Profiles Reveals CHRNA5-CHRNA3-CHRNB4 Gene Cluster Association With Several Nicotine Dependence Traits
- (2012) Ulla Broms et al. NICOTINE & TOBACCO RESEARCH
- BioGPS and MyGene.info: organizing online, gene-centric information
- (2012) Chunlei Wu et al. NUCLEIC ACIDS RESEARCH
- Divergent transcription: A new feature of active promoters
- (2011) Amy C. Seila et al. CELL CYCLE
- CpG islands and the regulation of transcription
- (2011) A. M. Deaton et al. GENES & DEVELOPMENT
- Relationship Between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 Variation and Smoking Behaviors and Lung Cancer Risk
- (2011) Catherine A. Wassenaar et al. JNCI-Journal of the National Cancer Institute
- Crosstalk between mRNA 3′ End Processing and Transcription Initiation
- (2010) Christophe K. Mapendano et al. MOLECULAR CELL
- Genome-wide evidence for an essential role of the human Staf/ZNF143 transcription factor in bidirectional transcription
- (2010) Yannick-Noël Anno et al. NUCLEIC ACIDS RESEARCH
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- Delivery of small-interfering RNA (siRNA) to the brain
- (2009) Saroj P Mathupala EXPERT OPINION ON THERAPEUTIC PATENTS
- Diversity of core promoter elements comprising human bidirectional promoters
- (2008) Mary Yang et al. BMC GENOMICS
- Significant association of the neurexin-1 gene (NRXN1) with nicotine dependence in European- and African-American smokers
- (2008) J. Nussbaum et al. HUMAN MOLECULAR GENETICS
- Conservation of divergent transcription in fungi
- (2008) Philip R. Kensche et al. TRENDS IN GENETICS
- Genetics of nicotinic acetylcholine receptors: Relevance to nicotine addiction
- (2007) Yann S. Mineur et al. BIOCHEMICAL PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More